Embecta (FRA:JX7) Total Liabilities : €1,812 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Total Liabilities?

Embecta's Total Liabilities for the quarter that ended in Mar. 2024 was €1,812 Mil.

Embecta's quarterly Total Liabilities declined from Sep. 2023 (€1,907.83 Mil) to Dec. 2023 (€1,844.36 Mil) and declined from Dec. 2023 (€1,844.36 Mil) to Mar. 2024 (€1,811.66 Mil).

Embecta's annual Total Liabilities increased from Sep. 2021 (€164.65 Mil) to Sep. 2022 (€1,997.58 Mil) but then declined from Sep. 2022 (€1,997.58 Mil) to Sep. 2023 (€1,907.83 Mil).

Embecta Total Liabilities Historical Data

The historical data trend for Embecta's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Total Liabilities Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Total Liabilities

140.93

164.65

1,997.58

1,907.83

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial											1,898.45	1,902.77	1,907.83	1,844.36	1,811.66

Embecta Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Embecta's Total Liabilities for the fiscal year that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	331.23	+	(1523	+	53.596
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,908

Total Liabilities	=	Total Assets (A: Sep. 2023 )	-	Total Equity (A: Sep. 2023 )
	=	1137.893	-	-769.933
	=	1,908

Embecta's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	285.568	+	(1492.792	+	33.304
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,812

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1103.632	-	-708.032
	=	1,812

Embecta Total Liabilities Related Terms

Thank you for viewing the detailed overview of Embecta's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines